A61P 5/36
Antigestagens
A61P5/36 (Antigestagens) appears on 135 US grants and 134 published applications in this corpus.
Search patents in A61P- Granted patents
- 135
- Published applications
- 134
- Assignees
- 75
- Inventors
- 336
- Latest grant
- 10 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 4 | 0 |
| 1998 | 12 | 0 |
| 1999 | 5 | 0 |
| 2000 | 9 | 0 |
| 2001 | 6 | 1 |
| 2002 | 8 | 5 |
| 2003 | 5 | 6 |
| 2004 | 7 | 10 |
| 2005 | 4 | 8 |
| 2006 | 3 | 2 |
| 2007 | 0 | 7 |
| 2008 | 3 | 9 |
| 2009 | 1 | 6 |
| 2010 | 11 | 10 |
| 2011 | 4 | 7 |
| 2012 | 3 | 10 |
| 2013 | 7 | 9 |
| 2014 | 5 | 11 |
| 2015 | 9 | 8 |
| 2016 | 6 | 7 |
| 2017 | 6 | 6 |
| 2018 | 4 | 5 |
| 2019 | 3 | 3 |
| 2020 | 1 | 1 |
| 2021 | 1 | 2 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders10 Dec 2024US 12,162,928 B2King's College London
- Prodrugs of the selective progesterone receptor modulator (SPRM) (11.beta.,17.beta.)-17-Hydroxy-11-[4-(methylsulphonyl)phenyl] -17-(pentafluoroethyl)estra-4,9-dien-3-one19 Jan 2021US 10,894,805 B2Bayer Pharma Aktiengesellschaft
- Formulations and methods for vaginal delivery of antiprogenstins11 Feb 2020US 10,555,900 B2Allergan Pharmaceuticals International Limited
- Selective progesterone receptor modulators (SPRM) and stabilized estrogen level in patient26 Nov 2019US 10,485,808 B2Bayer Pharma Aktiengesellschaft
- Method for treating gynecological diseases15 Oct 2019US 10,441,534 B2PregLem SA
- Progesterone receptor antagonist dosage form12 May 2022US 2022/0143045 A1Bayer Pharma Aktiengesellschaft
- Crystalline forms of selective progesterone receptor modulator, processes for preparation thereof10 Jun 2021US 2021/0171568 A1
- Novel VISTA-Ig constructs and the use of VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders20 May 2021US 2021/0147521 A1King's College London
- Formulations and methods for vaginal delivery of antiprogestins16 Jul 2020US 2020/0222315 A1Allergan Pharmaceuticals International Limited
- Prodrugs of the selective progesterone receptor modulator (sprm) (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one5 Dec 2019US 2019/0367555 A1Bayer Pharma Aktiengesellschaft
Most cited
By later US patents
- Method and composition for inhibiting cellular irreversible changes due to stress86US 5,801,159 AGalileo Laboratories, Inc. · 1998
- Tricyclic benzazepine vasopressin antagonists62US 5,753,648 AAmerican Cyanamid Company · 1998
- Bicyclic androgen and progesterone receptor modulator compounds and methods61US 6,566,372 B1Ligand Pharmaceuticals Incorporated · 2003
- Treatment of ovarian estrogen dependent conditions59US 5,681,817 AThe Medical College of Hampton Roads · 1997
- Devices for the delivery of drugs having antiprogestinic properties56US 6,476,079 B1Leiras Oy · 2002